Wednesday, July 8, 2026

pharma · Clostridium Difficile Infection · Ulcerative Colitis · MCRB

Seres Therapeutics

News and analysis for Seres Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

Cambridge, USA HQ
2010 Founded
129 Employees
Public company Type
MCRB · NYSE Ticker
Company details
Status
Public
HQ
Cambridge, USA
Founded
2010
Employees
129
Programs
8
Drugs
7
Patents
36
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Seres Therapeutics — regulatory, clinical, and market coverage.

News and analysis for Seres Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Seres Therapeutics yet.

Back to company overview →